HCW Biologics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HCW Biologics and other ETFs, options, and stocks.About HCWB
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases.
HCWB Key Statistics
Stock Snapshot
As of today, HCW Biologics(HCWB) shares are valued at $0.86. The company's market cap stands at 4.94M, with a P/E ratio of -0.06.
On 2026-03-18, HCW Biologics(HCWB) stock traded between a low of $0.80 and a high of $1.04. Shares are currently priced at $0.86, which is +6.8% above the low and -17.5% below the high.
The HCW Biologics(HCWB)'s current trading volume is 9.21M, compared to an average daily volume of 48.04M.
During the past year, HCW Biologics(HCWB) stock moved between $0.47 at its lowest and $17.80 at its peak.
During the past year, HCW Biologics(HCWB) stock moved between $0.47 at its lowest and $17.80 at its peak.
HCWB News
HCW Biologics (HCWB) announced the receipt of full payment of the upfront license fee with a value of $7M from its licensee, Beijing Trimmune Biotech. Trimmune...
HCW Biologics (HCWB) “announced results of groundbreaking research studies, published in the peer-reviewed, high-impact journal, Science Advances. These studies...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.